StocksTelegraph
S&P 500—NASDAQ—DOW—RUSSELL—
NASDAQ · IXHL·Healthcare

Incannex Healthcare Limited Stock Analysis & AI Score

Incannex Healthcare Limited (IXHL) has an ST Score of 54.3 (B-), driven by its Financial Strength (A+) and held back by its Profitability (C-). IXHL last traded at $3.40.

Market Closed
$3.40
Prev Close
—
Market Cap
—
Day Range
—
52W Range
—
P/E
—
EPS (TTM)
—
Volume
—
Avg —
Beta
—
54
ST Score
54.3/100B-

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of
AI Daily Briefing
Analysis by AI
Price History
—
Technical Indicators
FMP
Earnings Surprises
Analyst Forecast
Revenue Mix

Company Information

Employees—
CEO—
SectorHealthcare
IndustryBiotechnology
IPO Date—
Website—
Country—
ExchangeNASDAQ

SEC Filings

Annual Report (10-K)

Filing DateAcceptedLink
Loading…

Quarterly Report (10-Q)

Filing DateAcceptedLink
Loading…
Analyst Price Target
ESG Score
Latest News

ST Score

IXHL
54.3out of 100
Grade B-

Incannex Healthcare Limited (IXHL) has an ST Score of 54.3 (B-), driven by its Financial Strength (A+) and held back by its Profitability (C-). IXHL last traded at $3.40.

Strongest
Financial StrengthA+
Weakest
ProfitabilityC-
All factor grades
  • Financial StrengthA+
  • ValuationB
  • MomentumB-
  • GrowthC+
  • ProfitabilityC-
  • Piotroski3/9
Score methodology
Press Releases

Contact

IXHL stock: frequently asked questions

What is IXHL's ST Score?

Incannex Healthcare Limited (IXHL) has an ST Score of 54.3 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is IXHL a buy, hold, or sell?

Our ST Score grades it B- (54.3/100). The ST Score is a data-driven signal, not a recommendation.

What are IXHL's factor grades?

Valuation B, Profitability C-, Financial Strength A+, Momentum B-, Growth C+.

What is IXHL's valuation grade?

Incannex Healthcare Limited (IXHL) earns a valuation grade of B, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is IXHL's growth grade?

Incannex Healthcare Limited (IXHL) earns a growth grade of C+, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is IXHL's profitability grade?

Incannex Healthcare Limited (IXHL) earns a profitability grade of C-, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is IXHL's financial strength grade?

Incannex Healthcare Limited (IXHL) earns a financial strength grade of A+, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

What is IXHL's Piotroski score?

Incannex Healthcare Limited (IXHL) has a Piotroski F-Score of 3 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.